Effects of Single and Multiple Dose Tiotropium/Olodaterol in Chronic Obstructive Pulmonary Disease on Alveolar Gas Exchange Measured by Hyperpolarized 129Xe MRI.
Sep 2026· Journal of Magnetic Resonance Imaging· 1 citation· 28 references
Medicine
TL;DR
Single-dose TIO/OLO increased 129Xe in RBC-Gas and septal thickness but not RBC-M, and multiple-dose treatment significantly increased RBC-Gas, M-Gas and M T2* compared with single-dose treatment, but not RBC-M.
Abstract
Background
Long-acting muscarinic antagonists/long-acting beta adrenoreceptor agonists lead to lung deflation and improved microvascular perfusion in hyperinflated chronic obstructive pulmonary disease (COPD), but with an unclear time course.
Purpose
To investigate the effect of inhalation of tiotropium/olodaterol (TIO/OLO) on MRI measures of gas uptake and microvascular blood volume after single and multiple doses.
STUDY TYPE
Prospective, randomized, investigator-blinded, placebo-controlled single-dose crossover study with open-label multiple-dose extension.
POPULATION
31 participants with COPD and lung hyperinflation (residual volume > 135% predicted, ≥ 10 pack-years smoking).
FIELDSTRENGTH/SEQUENCE
1.5 T/Interleaved 3D radial gas and dissolved-phase MRI using multi-echo FLASH, high-resolution spectroscopy, chemical shift saturation recovery spectroscopy.
ASSESSMENT
Ratios of 129Xe in membrane tissues (M) to gas (M-Gas), red blood cells (RBC) to gas (RBC-Gas), RBC to M (RBC-M) were calculated from dissolved-phase imaging. Dissolved-phase apparent transverse relaxation times (T2*) from high-resolution spectra were also calculated, and septal wall thickness and surface-volume ratio (S/V) were assessed by fitting a model of xenon exchange functions. Parameters were compared for single-dose (5 μg/5 μg TIO/OLO) versus placebo using saline, and single-dose versus multiple-dose (daily 5 μg/5 μg TIO/OLO for 14 days) treatments.
STATISTICAL TESTS
Linear mixed models with contrasts of estimated marginal means, significance level 0.05.
Results
Compared with placebo, single-dose treatment significantly increased RBC-Gas and septal thickness but not RBC-M (p = 0.06), M-Gas (p = 0.16), RBC T2* (p = 0.13), M T2* (p = 0.09) and S/V (p = 0.47). Multiple-dose treatment significantly increased RBC-Gas, M-Gas and M T2* compared with single-dose treatment, but not RBC-M (p = 0.82), RBC T2* (p = 0.48), septal thickness (p = 0.61), and S/V (p = 0.49).
DATA
Conclusion
Single-dose TIO/OLO increased 129Xe in RBC-Gas. Multiple-dose treatment increased M-Gas and further increased RBC-Gas compared to single-dose treatment.
TECHNICAL EFFICACY
Stage 4.
EVIDENCE LEVEL
2.
INTRODUCTION
Ventilation heterogeneity is a feature of asthmatic bronchoconstriction and contributes to airway hyperresponsiveness and disease expression. This study characterized ventilation heterogeneity using hyperpolarized helium-3 magnetic resonance imaging (HP-MRI) in patients with mild asthma following methachol...
C. Foo, K. Nilsen, P. Noble et al.· Journal of applied physiolog...· 0 citations
BACKGROUND AND OBJECTIVE
Non-invasive ventilation (NIV) and inhaled bronchodilator therapy are foundational in the management of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). However, optimal drug-delivery strategies during NIV remain uncertain. This study compared bronchodilator delivery via a...
Vishal Raj, P. K. Singh, Rama S. Akondy et al.· Respirology (Carlton South....· 0 citations
Background: Non-cystic fibrosis (CF) bronchiectasis is a chronic respiratory disease characterized by permanent dilatation of the airways. The patients usually suffer from chronic daily phlegm and breathlessness. Recurrent infections and exacerbations result in the decline of lung function and quality of life. Chronic...
Background: Chronic obstructive pulmonary disease (COPD) is associated with affection of the cerebral vasculature, resulting in a higher incidence of stroke and cognitive decline. The exact pathophysiological background is not known, but among others, an altered function of the cerebral microvasculature is proposed as...
Regina Szabó-Szűcs, B. Fülesdi, Viktória Dudás et al.· Journal of Clinical Medicine· 0 citations
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce mortality in left heart failure. In pre-capillary pulmonary hypertension (PH), preclinical data suggest SGLT2i may improve right ventricular (RV) function through metabolic modulation, reduced perivascular inflammation, and inhibition of vascular remodelin...
M. Ersbøll, J. Kjaergaard, F. Gustafsson et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.